Carregando...
Bevacizumab and breast cancer: current therapeutic progress and future perspectives
Bevacizumab is a humanized monoclonal antibody to VEGF, and the incorporation of bevacizumab to chemotherapy is one of the rapidly evolving areas in the treatment of breast cancer. Bevacizumab in combination with chemotherapy versus chemotherapy alone improves progression-free survival and increases...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2819039/ https://ncbi.nlm.nih.gov/pubmed/19954282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.09.153 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|